ClinicalTrials.gg
CompletedNCT04373863LB1901Updated Oct 11, 2023

Assessment of Lifestyle, Blood Pressure, Cholesterol and Glycated Hemoglobin in a Specific Population

An observational study in Cholesterol; Lipidosis, Arterial Hypertension and Blood Glucose, High, sponsored by Libbs Farmacêutica LTDA. Completed at 1 site in Brazil. Open to participants aged 20 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-11.

Sponsored by Libbs Farmacêutica LTDA · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,472
Ages
20 Years and older
Sex
All
01

Study summary

The project Shall we get to know your health better? Lifestyle assessment, blood pressure and cholesterol in the population of Libbs Farmacêutica employeesLTDA.; consists of a study that will bring knowledge and enable quantificationof risk factors related to cardiovascular diseases in this population above mentioned.

Read the detailed description

The social relevance of this study is related to the knowledge and quantification of eating habits and lifestyles related to cardiovascular diseases in the population of employees, also referred to in this document as "employees", from Libbs Farmacêutica Ltda. Based on an observation and statistical analysis of the data obtained in this study, internal policies will be promoted that aim to improve eating habits, physical activity and decrease smoking.

02

Conditions studied

  • Cholesterol; Lipidosis
  • Arterial Hypertension
  • Blood Glucose, High

Keywords

  • glycated hemoglobin
  • Cholesterol
  • Arterial Hypertension
  • smoking
03

In context

Lipidoses

16 studies on the registry are indexed under Lipidoses; 3 are open to participants now.

Browse Lipidoses studies →

Lead sponsor

Libbs Farmacêutica LTDA is the lead sponsor of 10 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

This research project will be conducted during various internal and external institutional events, and in specific actions carried out at Libbs units located in Barra Funda (administrative unit) and in the city of Embu das Artes (production unit).

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being an employee Libbs Farmacêutica Ltda;

Exclusion criteria

Exclusion Criteria:

  • not applicable
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,472 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Descriptive questionnaire

    Descriptive information about lifestyle and family history and through exams, blood pressure and serum cholesterol values in the population of Libbs Farmacêutica Ltda employees.

    Time frame: until December 2020

Secondary outcomes

  1. Prevalence of hypercholesterolemia and arterial hypertension

    Quantify the prevalence of hypercholesterolemia (serum total cholesterol above 200mg / dL - worst case) and hypertension (systolic blood pressure above 140mmHg or diastolic blood pressure above 90mmHg - worst case)

    Time frame: until December 2020

  2. Glycated hemoglobin (HbA1c) values

    Track the glycated hemoglobin (HbA1c) values of the research participants, in order to know the average blood glucose levels in the last 3 months before the day of the exam and quantify the prevalence of participants who have HbA1c above the value considered normal in literature, which is up to 5.6% (best scenario)

    Time frame: until December 2020

  3. Data correlation

    * Correlate eating habits with socioeconomic characteristics; * Correlate the values of serum cholesterol, blood pressure and glycated hemoglobin with eating habits, level of physical activity practiced and prevalence of smoking

    Time frame: until December 2020

07

Study locations

1 site
  • Augusto Theodoro de Figueiredo
    São Paulo, 01140050, Brazil
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2020 to primary completion in Aug 2021, 14 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2020
First posted
May 5, 2020
StartActual
Jun 29, 2020
Primary completionActual
Aug 30, 2021
CompletionActual
Jan 19, 2023
Last update
Oct 11, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04373863
Lead sponsor
Libbs Farmacêutica LTDA
Responsible party
Sponsor
First posted
May 5, 2020
Start date
Jun 29, 2020
Primary completion
Aug 30, 2021
Completion
Jan 19, 2023
Last update
Oct 11, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion